Jazz Pharmaceuticals, Inc. (JAZZ) to Present at Investor Conference
11/11/2009 9:46:42 AM
More...
|
Jazz Pharmaceuticals, Inc. (JAZZ) Announces Third Quarter 2009 Financial Results -Achieved Record Quarterly Net Product Sales of $30 Million - Raising Revenue Guidance for 2009
11/6/2009 9:47:13 AM
More...
|
Jazz Pharmaceuticals, Inc. (JAZZ) to Announce Third Quarter Financial Results on November 5, 2009
10/30/2009 9:07:46 AM
More...
|
Data from Jazz Pharmaceuticals, Inc. (JAZZ) First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences
10/15/2009 8:17:42 AM
More...
|
Jazz Pharmaceuticals, Inc. (JAZZ) to Present at Two Upcoming Investor Conferences
9/4/2009 8:34:14 AM
More...
|
Jazz Pharmaceuticals, Inc. (JAZZ) Announces Second Quarter 2009 Financial Results - Net Product Sales Reach Record $26.5 Million
8/12/2009 8:07:18 AM
More...
|
Jazz Pharmaceuticals, Inc. (JAZZ) to Announce Second Quarter Financial Results on August 11, 2009
8/10/2009 10:50:28 AM
More...
|
Jazz Pharmaceuticals, Inc. (JAZZ) Pays Accrued Interest Under Senior Secured Notes
7/7/2009 10:04:09 AM
More...
|
Jazz Pharmaceuticals, Inc. (JAZZ) Completes $7 Million Private Placement
7/7/2009 9:43:59 AM
More...
|
Jazz Pharmaceuticals, Inc. (JAZZ) And UCB Group (UCBJF.PK) Announce Second Phase III Study Of Sodium Oxybate In Patients With Fibromyalgia Meets Primary Endpoints
6/25/2009 10:03:26 AM
More...
|
|